A single-centre retrospective analysis of cinacalcet therapy in primary hyperparathyroidism
Primary hyperparathyroidism (pHPT) is a common endocrine disorder that can be cured by parathyroidectomy; patients unsuitable for surgery can be treated with cinacalcet. Availability of surgery may be reduced during COVID-19, and cinacalcet can be used as bridging therapy. In this single-centre retr...
Guardado en:
Autores principales: | Daniel Bell, Julia Hale, Cara Go, Ben G Challis, Tilak Das, Brian Fish, Ruth T Casey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Bioscientifica
2021
|
Materias: | |
Acceso en línea: | https://doi.org/10.1530/EC-21-0258 https://doaj.org/article/4ebafbe31ad84dc6ac02710a0db56610 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intensive calcium monitoring improves outcomes on hungry bone syndrome in hyperparathyroidism
por: Ferreira Joana Lima, et al.
Publicado: (2021) -
Changes in clinical patterns of Chinese patients with primary hyperparathyroidism in the past 12 years: a single-center experience
por: Yuan Liu, et al.
Publicado: (2021) -
A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves’ disease
por: Baldane S, et al.
Publicado: (2016) -
Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism
por: Wenjing Ni, et al.
Publicado: (2021) -
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
por: Maha A. Behairy, et al.
Publicado: (2022)